Semaglutide Weight Management and Cardiovascular Risk Reduction slide image

Semaglutide Weight Management and Cardiovascular Risk Reduction

HFPEF compromises -50% of all HF cases, and -80% of HFPEF patients live with overweight or obesity Heart failure with preserved ejection fraction • Impaired filling capacity Stiff and thick ventricle LVEF ≥50% Approximately 26 million people have HFPEF and BMI>271,2 64m 32m 26m تھی Patients with HFPEF are under a great burden³ Higher mortality rate Higher risk of hospitalisation Higher burden of debilitating symptoms, physical limitations and poor quality of life The key goals of therapy³ Prolong survival Reduce hospitalisations Reduce symptoms; improve quality of life and functional status HF HFPEF Prevalence of HFPEF and BMI>27 1. Groenewegen A et al. Eur J Heart Fail 2020;22:1342-13561; Gurwitz JH et al. Am J Med 2013;126:393-400; 2. Haass M et al. Circulation 2011;4:324-331; Kitzman DW, et al. J Am Coll Cardiol 2016;68:200-203 3. Ponikowski P et al. Eur J Heart Fail 2016;18:891-975 LVEF: Left ventricular ejection fraction; HF: Heart failure; HFPEF: Heart Failure with preserved ejection fraction
View entire presentation